Skip to content

Save the Date: Skyline Courses at ISAS from July 25 to 29

Dortmund, 29th June 2022

+++ Unfortunately, the courses planned for July 2022 have to be postponed. Together with the instructors, ISAS is currently doing everything in its power to quickly search for a replacement date. +++

SRM/MRM-, PRM- and DIA-data or MS1-filtering – for those who are familiar with these abbreviations as well as for beginners, ISAS will be hosting courses on the use of the open source software Skyline for (un)targeted proteomics and metabolomics, lipidomics as well as glycomics, from July 25 to 29, 2022. New and advanced users from science and industry can choose from the following multi-day courses in Dortmund:

  1. Skyline Proteomics Beginner
    July 25 to 27, 2022
    (maximum of 30 participants)
    Course fee incl. catering and social programme:
    300 euros (academic) / 750 euros (industry)
     

  2. Skyline Proteomics Advanced
    July 28 to 29, 2022
    (maximum of 30 participants)
    Course fee incl. catering and social programme:
    250 euros (academic) / 500 euros (industry)
     

  3. Skyline Small Molecules
    July 28 to 29, 2022
    (maximum of 10 participants)
    Course fee incl. catering and social programme:
    250 euros (academic) / 500 euros (industry)

Speakers include Skyline developer Brendan MacLean (University of Washington), Dr Isabell Bludau (Max Planck Institute of Biochemistry), Prof Dr Ursula Klingmüller (German Cancer Research Center, DKFZ) and Dr Christina Ludwig (Bavarian Centre for Biomolecular Mass Spectrometry, BayBioMS).

Details on the registration as well as information on the social programme will follow shortly. If you have any questions, please contact Roman Sakson from the Proteomics research group. 

Share

Further articles

Endogenous Antioxidant Promotes Breast Cancer Cells in the Lung

Oxidative stress puts pressure on metastasising tumour cells – yet they can activate defence mechanisms to cope with it. Prof. Dr Dr Alpaslan Tasdogan explains the specific challenges faced by breast cancer cells in the lungs. In the interview, he discusses the therapeutic potential of specifically targeting these defence mechanisms of tumour cells in the future.

Prof. Dr. Dr. Apaslan Tasdogan.

An AI Agent That Understands the Language of Science

A colleague who never sleeps, never gets tired and completes complex analyses in minutes: a new AI agent for biomedical research is to be developed at ISAS.

Endogenous Antioxidant Promotes Breast Cancer Cells in Lungs

How do breast cancer cells manage to establish themselves in the lungs and survive there? Researchers at ISAS are investigating which metabolic processes help the tumour cells to adapt to their new environment. The findings provide new insights into the early stages of metastases.

From Human Stem Cells to Mice: Research into New Treatments for Heart Failure

What can human stem cells tell us, and why are mice still essential for developing new therapies for people with heart failure? In our collaborative project HI-FIVE, scientists and physicians work with both animal-free methods and, for some research questions, with mice. In this article marking World Day for Laboratory Animals, our animal welfare officer and the lead researcher of HI-FIVE explain why.

Mäuse in einer Haltungseinheit mit rotem Häuschen, Nistmaterial, Holzkugel und transparenter Röhre zur Beschäftigung und als Rückzugsmöglichkeit.

Four Perspectives on a Shared Discovery

Although CD177⁺ and CD177⁻ neutrophils look identical under the microscope, they are in fact not the same. Four of the authors of “CD177 Deficiency Defines a Stable Subtype of Human Neutrophil Granulocytes with Tumour-Promoting Activity” (Advanced Science) explain how they identified the functional differences between these immune cells and which combined analytical methods made their discovery possible in the first place. This insight into their research demonstrates how interdisciplinary collaboration can reveal previously undiscovered information.

Das Foto zeigt im oberen Teil Porträts von vier Wissenschaftlern. Von links nach rechts: Prof. Dr. Matthias Gunzer, Prof. Dr. Jianxu Chen, Dr. Belal Alshaar, Prof. Dr. Albert Sickmann. Im Teil unter den Porträts sind Mikroskopaufnahmen von CD177-definierten Neutrophilen zu sehen.

3 Questions for... Neele Rottmann

In the lab, Neele Rottmann prepares human and animal samples for mass spectrometry analysis. As part of the HI-FIVE project, she is helping to identify changes at the protein level in heart failure. Why does she spend so much time in the lab working on separations? The technical assistant shares the answer in this interview.

Neele Rottmann is wearing a white lab coat and purple gloves and is operating a mass spectrometry analyser in a laboratory. Next to her is a liquid chromatography system connected to a mass spectrometer via several tubes. There are numerous sample vials on the instrument. As she places a sample into the system, she looks into the camera.

High-tech against Cardiovascular Diseases: 3D Images of Blood Vessels

How do atherosclerotic plaques form in the coronary arteries? At ISAS, researchers are investigating cellular changes in human coronary arteries using techniques such as 3D imaging. During her internship, early-career researcher Leonie Menzel used a light sheet fluorescence microscope to analyse the spatial distribution of individual cells within the tissue. She thereby gained valuable methodological experience for her Master’s thesis.

3 Questions for Lukas Fu

How can AI support the analysis of biomedical images? This was the question Lukas Fu explored during his school internship at ISAS. The 15-year-old also successfully completed his first programming project.

Lukas Fu, a 15-year-old with short black hair. He is wearing glasses and is sitting on a low wall.

Separating Fluorescence Signals Faster and More Precisely with AI

When different fluorescence signals overlap during microscopy, their clear assignment to specific biological structures becomes difficult. To address this common problem, Dr Davide Panzeri is developing AI-based signal separation methods. The biophysicist has been awarded a Marie Skłodowska-Curie Fellowship by the European Union for his promising research project.

Porträt Dr. Davide Panzeri.